Finance

Beta
Lists
AVG:FRA
Avantor Inc
€7.75
+8.76%
(+0.62) 1D
May 29, 8:04:44 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for AVG...
Open
€7.75
High
€7.75
Low
€7.75
Mkt. cap
6.36B
Avg. vol.
29.00
Volume
0.00
52-wk high
€13.40
52-wk low
€6.30
No. of employees
14K
Open
€7.75
High
€7.75
Low
€7.75
Mkt. cap
6.36B
Avg. vol.
29.00
Volume
0.00
52-wk high
€13.40
52-wk low
€6.30
No. of employees
14K
News stories
From sources across the web
Profile
Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”. Wikipedia
About Avantor Inc
CEOEmmanuel Ligner
Employees13.5K
Founded1904
HeadquartersRadnor Township, Pennsylvania, United States
SectorHealth care
Websiteavantorsciences.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.68B
1.62B
1.66B
1.58B
Cost of goods sold
1.13B
1.10B
1.14B
1.08B
Cost of revenue
1.13B
1.10B
1.14B
1.08B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
425.60M
388.80M
338.40M
401.70M
Operating expense
425.60M
388.80M
338.40M
401.70M
Total operating expenses
1.55B
1.49B
1.48B
1.48B
Operating income
128.50M
137.70M
185.50M
99.00M
Other non operating income
500.00K
700.00K
-7.00M
-
EBT including unusual items
81.70M
-689.50M
80.80M
55.50M
EBT excluding unusual items
81.70M
95.70M
136.40M
56.10M
Income tax expense
17.00M
22.30M
28.40M
12.20M
Effective tax rate
20.81%
-3.23%
35.15%
21.98%
Other operating expenses
-
-
-
-
Net income
64.70M
-711.80M
52.40M
43.30M
Net profit margin
3.84%
-43.84%
3.15%
2.74%
Earnings per share
0.24
0.22
0.22
0.17
Interest and investment income
11.00M
11.90M
11.40M
10.50M
Interest expense
-54.40M
-58.00M
-53.40M
-53.40M
Net interest expenses
-43.40M
-46.10M
-42.00M
-42.90M
Depreciation and amortization charges
-
-
-
-
EBITDA
231.20M
242.20M
288.80M
204.00M
Gain or loss from assets sale
-
-
5.10M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer